Literature DB >> 21508698

Uterine carcinosarcoma.

Sherif A El-Nashar1, Andrea Mariani.   

Abstract

Carcinosarcoma is a rare but highly aggressive uterine malignancy. Pathologically, carcinosarcoma is a biphasic neoplasm composed of a mixture of malignant epithelial and mesenchymal components. A comprehensive approach for management is recommended with complete surgical staging to assess tumor dissemination followed by multimodal therapy with combinations of external beam irradiation or vaginal brachytherapy and systematic chemotherapy in patients with both early and advanced stage disease.

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21508698     DOI： 10.1097/GRF.0b013e31821ac635

Source DB:  PubMed          Journal:  Clin Obstet Gynecol        ISSN： 0009-9201            Impact factor:   2.190


  23 in total

1.  Proceedings of the 2013 National Toxicology Program Satellite Symposium.

Authors:  Susan A Elmore; Michael C Boyle; Molly H Boyle; Michelle C Cora; Torrie A Crabbs; Connie A Cummings; Margarita M Gruebbel; Crystal L Johnson; David E Malarkey; Elizabeth F McInnes; Thomas Nolte; Cynthia C Shackelford; Jerrold M Ward
Journal:  Toxicol Pathol       Date:  2013-12-13       Impact factor: 1.902

2.  Patterns of care, predictors, and outcomes of chemotherapy in elderly women with early-stage uterine carcinosarcoma: a population-based analysis.

Authors:  Gunjal Garg; Cecilia Yee; Kendra Schwartz; David G Mutch; Robert T Morris; Matthew A Powell
Journal:  Gynecol Oncol       Date:  2014-02-19       Impact factor: 5.482

3.  Malignant mixed müllerian tumor mimicking cervical carcinoma.

Authors:  Ana Marija Alduk; Marija Macan; Maja Prutki
Journal:  Wien Klin Wochenschr       Date:  2016-08-17       Impact factor: 1.704

4.  The FOXA2 transcription factor is frequently somatically mutated in uterine carcinosarcomas and carcinomas.

Authors:  Matthieu Le Gallo; Meghan L Rudd; Mary Ellen Urick; Nancy F Hansen; Maria J Merino; David G Mutch; Paul J Goodfellow; James C Mullikin; Daphne W Bell
Journal:  Cancer       Date:  2017-09-21       Impact factor: 6.860

Review 5.  Review of Recommended Treatment of Uterine Carcinosarcoma.

Authors:  Joseph Menczer
Journal:  Curr Treat Options Oncol       Date:  2015-11

6.  Malignant mixed Mullerian tumour of uterus secondary to tamoxifen therapy for hormone responsive breast cancer.

Authors:  Mayank Gupta; Kala Gnanasekaran Kiruthiga
Journal:  BMJ Case Rep       Date:  2015-06-29

Review 7.  Epithelial to mesenchymal transition in the pathogenesis of uterine malignant mixed Müllerian tumours: the role of ubiquitin proteasome system and therapeutic opportunities.

Authors:  I A Voutsadakis
Journal:  Clin Transl Oncol       Date:  2012-04       Impact factor: 3.405

Review 8.  Magnetic Resonance Imaging in Mixed Mullerian Tumour: Report of Two Cases.

Authors:  Pratiksha Yadav; Vidhi Bakshi; Rajul Bhargava
Journal:  J Clin Diagn Res       Date:  2017-03-01

Review 9.  Adjuvant radiotherapy and/or chemotherapy after surgery for uterine carcinosarcoma.

Authors:  Khadra Galaal; Esther van der Heijden; Keith Godfrey; Raj Naik; Ali Kucukmetin; Andrew Bryant; Nagindra Das; Alberto D Lopes
Journal:  Cochrane Database Syst Rev       Date:  2013-02-28

10.  Carcinosarcoma of the uterus-a single institution retrospective analysis of the management and outcome and a brief review of literature.

Authors:  Rajanbabu Anupama; Santhosh Kuriakose; D K Vijaykumar; K Pavithran; Annie Jojo; R Nair Indu; V S Sheejamol
Journal:  Indian J Surg Oncol       Date:  2013-01-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.